Emerging Diagnostic Imaging Market by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Size, Opportunities, Segmentation and Forecast 2015 – 2021
The emerging diagnostic imaging market is segmented on the basis of applications such as advanced conventional technologies, remote diagnostics, point-of-care diagnostics, nuclear medicine, biomarkers, imaging agents and other emerging technologies. The report includes emerging technologies which are commercialized and which are going through final phases of approvals. Market covered in the emerging diagnostic imaging are North America, Latin America, Europe, Middle-East and Africa (MEA) and Asia-Pacific.
The diagnostic equipment of conventional technologies are over burdened with the hospitals and diagnostic centers having limited resources and budgets, especially in emerging markets like India and China. Hence there is requirement of machines that are capable of performing multiple diagnoses. Portable diagnostic machines are one of the major advancement which enables providing point-of-care assistance and reaching out to more number of patients.
United States being the largest healthcare market is number one in making changes so that healthcare can become more affordable to people. There is an increase in demand of services as well as products that are value based in the industry that lacks resources as well as skills. Opportunities are growing for the industry with the emergence of new markets. They are situated in the developing economies with ever changing needs.
This Occams Research Report covers
1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2021
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. Deep profiles top competitive companies
The diagnostic equipment of conventional technologies are over burdened with the hospitals and diagnostic centers having limited resources and budgets, especially in emerging markets like India and China. Hence there is requirement of machines that are capable of performing multiple diagnoses. Portable diagnostic machines are one of the major advancement which enables providing point-of-care assistance and reaching out to more number of patients.
United States being the largest healthcare market is number one in making changes so that healthcare can become more affordable to people. There is an increase in demand of services as well as products that are value based in the industry that lacks resources as well as skills. Opportunities are growing for the industry with the emergence of new markets. They are situated in the developing economies with ever changing needs.
This Occams Research Report covers
1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2021
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. Deep profiles top competitive companies
CHAP 1. EXECUTIVE SUMMARY
CHAP 2. KEY FINDINGS
2.1. Finding 1: What is the need of hour for med imaging cos? – Patient care/Innovations/Cost/Novel Business Model?
2.2. Finding 2: How are regulations to affect the future market?
2.3. Finding 3: Brown Water Strategy – Understanding Regional Markets
CHAP 3. SECTOR ANALYSIS: MEDICAL DEVICES MARKET
3.1. Orientation to Diagnostic Imaging Systems
CHAP 4. REGULATORY IMPLICATIONS
4.1. INTRODUCTION
4.1.1. Europe
4.1.1.1. ROHS II
4.1.2. U.S.
4.1.2.1. Class I devices
4.1.2.2. Class II devices
4.1.2.3. Class III devices
4.2. China
4.2.1. Japan
4.2.2. India
4.2.3. Indonesia
4.2.4. Korea
4.2.5. Malaysia
4.2.6. The Philippines
4.2.7. Singapore
4.2.8. Taiwan
4.2.9. Australia
4.2.10. Hong Kong
4.2.11. Vietnam
CHAP 5. MARKET DETERMINANTS
5.1. Market Drivers
5.1.1. Aging population- A global issue to boost the need for diagnostics
5.1.2. Increase in lifestyle and chronic diseases
5.1.3. Other drivers include:
5.1.3.1. Limitations and Restrictions
5.1.3.2. Some other restrictive factors that are likely to impact the industry negatively are:
5.1.4. Opportunities
CHAP 6. DIAGNOSTIC IMAGING DEVICES MARKET
6.1. Magnetic Imaging Resonance (MRI) System
6.2. Rest of World
6.2.1. Market Dynamics
6.2.2. Competitive Intelligence & Key Strategies
6.2.2.1. GE Healthcare
6.2.2.2. Toshiba
6.2.2.3. Siemens
6.2.2.4. Hitachi
6.2.2.5. Philips
6.2.3. Market Share of Key Companies, 2012
6.2.4. Market Trends and Determinants
6.2.5. Geographic Analysis
6.2.5.1. Ultrasound Technologies Market
6.2.6. Market Trends and Determinants
6.2.7. Competitive Intelligence & Key Strategies
6.2.8. Geographic Analysis
6.2.9. Laser Imaging Market
6.2.10. Market Determinants
6.2.11. Competitive Intelligence and Key Strategies
6.2.12. Company Market Share, 2012
6.2.13. Geographic Analysis
6.2.13.1. Interventional Radiology Market
6.2.14. Market Trends and Determinants
6.2.15. Competitive intelligence and Key strategies
6.2.16. Geographic Analysis
6.2.16.1. X-ray
6.2.17. Market determinants
6.2.18. Competitive Intelligence & key Strategies
6.2.19. Market share of key players, 2012
6.2.20. Geographic Analysis
6.2.20.1. Nuclear Medicine
6.2.21. Market determinants
6.2.22. Competitive Intelligence & Key Strategies
6.2.23. Market share of key players, 2012
6.2.24. Geographic Analysis
CHAP 7. GEOGRAPHY ANALYSIS
7.1. North America
7.1.1. U.S.
7.1.2. Canada
7.1.2.1. Europe
7.1.3. Enabling people to live healthy and productive lives
7.1.4. Increasing the productivity and efficiency of healthcare systems
7.1.5. Contributing to economic growth
7.1.5.1. Benefits of the EU regulatory system in access to novel technologies
7.2. Asia
7.2.1. Population Size
7.2.2. Economics
7.2.3. Aging Populations
7.2.3.1. Asia's Growing Market for Cardiovascular Devices
7.2.4. RAPIDLY GROWING DEMAND
7.2.5. Each country in Asia has different medical device regulations and classifications, usually based on the level of risk to the patient.
7.2.5.1. Outsourcing Medical Devices to Asia: Trends and Tips
7.2.6. Conclusion
7.2.7. Increased Medical Device Regulations for Asia's New Tigers
7.2.8. China
7.2.8.1. Understanding the China Medical Device Market
7.2.8.2. China Regulatory Agency for Medical Devices
7.2.8.3. Major healthcare issues for China to tackle include
7.2.8.4. Healthcare Development in Rural and Urban Areas
7.2.8.5. Greater Private-Sector Opportunities
7.2.8.6. More Affordable Healthcare
7.2.8.7. Tighter Medical Device Regulations
7.2.8.8. The Battle Over China's Medical Device Market 2013
7.2.9. India
7.2.10. Japan
7.2.11. Korea
7.2.12. MALAYSIA
7.2.12.1. The Medical Device Act
7.2.12.2. The Medical Device Authority Act
7.2.13. INDONESIA
7.2.13.1. Infrastructure growth4
7.2.13.2. Online registration system
7.2.14. THAILAND
7.2.15. VIETNAM
7.2.16. SINGAPORE
7.2.17. South Korea
7.2.17.1. Rest of The World
7.2.18. Turkey
7.2.19. Iran
7.2.20. Brazil
CHAP 8. COMPANY PROFILES
8.1. LUMENIS LTD.
8.2. BIOLASE
8.3. PHOTOMEDEX
8.4. IRIDEX CORPORATION
8.5. SPECTRANETICS CORPORATION
8.6. GE HEALTHCARE
8.7. SIEMENS HEALTHCARE
8.8. PHILIPS HEALTHCARE
8.9. ABBOTT LABORATORIES
8.10. AGILENT TECHNOLOGIES
8.11. BIO RAD LABORATORIES
8.12. BRACCO IMAGING
8.13. CARDINAL HEALTH
8.14. COVIDIEN PLC
TABLE LIST
TABLE 1 GLOBAL MARKET FOR DIAGNOSTIC IMAGING devices, 2012 THROUGH 2018, $MILLION
TABLE 2 Global Medical Devices Market, 2012 through 2018, $Billion
TABLE 3 Diagnostic Imaging market by Products 2012 through 2018 $Millions
TABLE 4 No. of people with diabetes from 2010 to 2030
TABLE 5 Global MRI Market by geographies, 2012 through 2018, in millions
TABLE 6 Ultrasound Technologies Market by geographies, 2012 through 2018, in $millions
TABLE 7 Laser Imaging Market by geographies, 2012 through 2018, $millions
TABLE 8 Interventional Radiology Market, by geographies, 2012 through 2018, $millions
TABLE 9 TABLE8 X-Ray Market, by geography, 2012 through 2018, $millions
TABLE 10 Nuclear Medicine Market, by geography, 2012 through 2018, $millions
TABLE 11 Reimbursement policies laid out by the Centers for Medicare and Medicaid Services in the U.S.
TABLE 12 North America market for imaging devices, 2012 through 2018, $millions
TABLE 13 Europe imaging devices market, 2012 through 2018, $million
TABLE 14 ASIAN MARKET for imaging devices, 2012 through 2018, $million
TABLE 15 Market for South America, 2012 through 2018, USD Millions
TABLE 16 Market for Rest of World, 2012 through 2018, $Millions
CHAP 2. KEY FINDINGS
2.1. Finding 1: What is the need of hour for med imaging cos? – Patient care/Innovations/Cost/Novel Business Model?
2.2. Finding 2: How are regulations to affect the future market?
2.3. Finding 3: Brown Water Strategy – Understanding Regional Markets
CHAP 3. SECTOR ANALYSIS: MEDICAL DEVICES MARKET
3.1. Orientation to Diagnostic Imaging Systems
CHAP 4. REGULATORY IMPLICATIONS
4.1. INTRODUCTION
4.1.1. Europe
4.1.1.1. ROHS II
4.1.2. U.S.
4.1.2.1. Class I devices
4.1.2.2. Class II devices
4.1.2.3. Class III devices
4.2. China
4.2.1. Japan
4.2.2. India
4.2.3. Indonesia
4.2.4. Korea
4.2.5. Malaysia
4.2.6. The Philippines
4.2.7. Singapore
4.2.8. Taiwan
4.2.9. Australia
4.2.10. Hong Kong
4.2.11. Vietnam
CHAP 5. MARKET DETERMINANTS
5.1. Market Drivers
5.1.1. Aging population- A global issue to boost the need for diagnostics
5.1.2. Increase in lifestyle and chronic diseases
5.1.3. Other drivers include:
5.1.3.1. Limitations and Restrictions
5.1.3.2. Some other restrictive factors that are likely to impact the industry negatively are:
5.1.4. Opportunities
CHAP 6. DIAGNOSTIC IMAGING DEVICES MARKET
6.1. Magnetic Imaging Resonance (MRI) System
6.2. Rest of World
6.2.1. Market Dynamics
6.2.2. Competitive Intelligence & Key Strategies
6.2.2.1. GE Healthcare
6.2.2.2. Toshiba
6.2.2.3. Siemens
6.2.2.4. Hitachi
6.2.2.5. Philips
6.2.3. Market Share of Key Companies, 2012
6.2.4. Market Trends and Determinants
6.2.5. Geographic Analysis
6.2.5.1. Ultrasound Technologies Market
6.2.6. Market Trends and Determinants
6.2.7. Competitive Intelligence & Key Strategies
6.2.8. Geographic Analysis
6.2.9. Laser Imaging Market
6.2.10. Market Determinants
6.2.11. Competitive Intelligence and Key Strategies
6.2.12. Company Market Share, 2012
6.2.13. Geographic Analysis
6.2.13.1. Interventional Radiology Market
6.2.14. Market Trends and Determinants
6.2.15. Competitive intelligence and Key strategies
6.2.16. Geographic Analysis
6.2.16.1. X-ray
6.2.17. Market determinants
6.2.18. Competitive Intelligence & key Strategies
6.2.19. Market share of key players, 2012
6.2.20. Geographic Analysis
6.2.20.1. Nuclear Medicine
6.2.21. Market determinants
6.2.22. Competitive Intelligence & Key Strategies
6.2.23. Market share of key players, 2012
6.2.24. Geographic Analysis
CHAP 7. GEOGRAPHY ANALYSIS
7.1. North America
7.1.1. U.S.
7.1.2. Canada
7.1.2.1. Europe
7.1.3. Enabling people to live healthy and productive lives
7.1.4. Increasing the productivity and efficiency of healthcare systems
7.1.5. Contributing to economic growth
7.1.5.1. Benefits of the EU regulatory system in access to novel technologies
7.2. Asia
7.2.1. Population Size
7.2.2. Economics
7.2.3. Aging Populations
7.2.3.1. Asia's Growing Market for Cardiovascular Devices
7.2.4. RAPIDLY GROWING DEMAND
7.2.5. Each country in Asia has different medical device regulations and classifications, usually based on the level of risk to the patient.
7.2.5.1. Outsourcing Medical Devices to Asia: Trends and Tips
7.2.6. Conclusion
7.2.7. Increased Medical Device Regulations for Asia's New Tigers
7.2.8. China
7.2.8.1. Understanding the China Medical Device Market
7.2.8.2. China Regulatory Agency for Medical Devices
7.2.8.3. Major healthcare issues for China to tackle include
7.2.8.4. Healthcare Development in Rural and Urban Areas
7.2.8.5. Greater Private-Sector Opportunities
7.2.8.6. More Affordable Healthcare
7.2.8.7. Tighter Medical Device Regulations
7.2.8.8. The Battle Over China's Medical Device Market 2013
7.2.9. India
7.2.10. Japan
7.2.11. Korea
7.2.12. MALAYSIA
7.2.12.1. The Medical Device Act
7.2.12.2. The Medical Device Authority Act
7.2.13. INDONESIA
7.2.13.1. Infrastructure growth4
7.2.13.2. Online registration system
7.2.14. THAILAND
7.2.15. VIETNAM
7.2.16. SINGAPORE
7.2.17. South Korea
7.2.17.1. Rest of The World
7.2.18. Turkey
7.2.19. Iran
7.2.20. Brazil
CHAP 8. COMPANY PROFILES
8.1. LUMENIS LTD.
8.2. BIOLASE
8.3. PHOTOMEDEX
8.4. IRIDEX CORPORATION
8.5. SPECTRANETICS CORPORATION
8.6. GE HEALTHCARE
8.7. SIEMENS HEALTHCARE
8.8. PHILIPS HEALTHCARE
8.9. ABBOTT LABORATORIES
8.10. AGILENT TECHNOLOGIES
8.11. BIO RAD LABORATORIES
8.12. BRACCO IMAGING
8.13. CARDINAL HEALTH
8.14. COVIDIEN PLC
TABLE LIST
TABLE 1 GLOBAL MARKET FOR DIAGNOSTIC IMAGING devices, 2012 THROUGH 2018, $MILLION
TABLE 2 Global Medical Devices Market, 2012 through 2018, $Billion
TABLE 3 Diagnostic Imaging market by Products 2012 through 2018 $Millions
TABLE 4 No. of people with diabetes from 2010 to 2030
TABLE 5 Global MRI Market by geographies, 2012 through 2018, in millions
TABLE 6 Ultrasound Technologies Market by geographies, 2012 through 2018, in $millions
TABLE 7 Laser Imaging Market by geographies, 2012 through 2018, $millions
TABLE 8 Interventional Radiology Market, by geographies, 2012 through 2018, $millions
TABLE 9 TABLE8 X-Ray Market, by geography, 2012 through 2018, $millions
TABLE 10 Nuclear Medicine Market, by geography, 2012 through 2018, $millions
TABLE 11 Reimbursement policies laid out by the Centers for Medicare and Medicaid Services in the U.S.
TABLE 12 North America market for imaging devices, 2012 through 2018, $millions
TABLE 13 Europe imaging devices market, 2012 through 2018, $million
TABLE 14 ASIAN MARKET for imaging devices, 2012 through 2018, $million
TABLE 15 Market for South America, 2012 through 2018, USD Millions
TABLE 16 Market for Rest of World, 2012 through 2018, $Millions
FIGURES LIST
Figure 1 Health expenditure 2009 - 2011, total (% of GDP)
Figure 2 Percentage Share of regions in Medical device technology market, 2012
Figure 3 Global Percentage of population over 60 years of Age in 2013
Figure 4 Growth of diabetics across the world: Comparative prevalence (%) of Diabetes and IGT
Figure 5 Number of people with diabetes (millions)
Figure 6 Worldwide patients with chronic diseases, 2005–2030
Figure 7 Market Share of Key Companies, 2012
Figure 8 Top 10 countries with the highest share of 60+ populations, 2011
Figure 9 Top 10 countries with the expected highest share of 60+ populations, 2050
Figure 10 Company Market Share, 2012
Figure 11 Global Alzheimer prevalence, 2010-2050 (million)
Figure 12 Company Market Share, 2012
Figure 13 Global angioplasty procedures conducted, 2009-2012
Figure 14 Global stents in coronary procedures, 2009-2012
Figure 15 PACS Implementation Process
Figure 16 Global percentage of population, by age-group
Figure 17 Market share of key players, 2012
Figure 18 Cardiovascular mortality percentage, by country income level, 2011
Figure 1 Health expenditure 2009 - 2011, total (% of GDP)
Figure 2 Percentage Share of regions in Medical device technology market, 2012
Figure 3 Global Percentage of population over 60 years of Age in 2013
Figure 4 Growth of diabetics across the world: Comparative prevalence (%) of Diabetes and IGT
Figure 5 Number of people with diabetes (millions)
Figure 6 Worldwide patients with chronic diseases, 2005–2030
Figure 7 Market Share of Key Companies, 2012
Figure 8 Top 10 countries with the highest share of 60+ populations, 2011
Figure 9 Top 10 countries with the expected highest share of 60+ populations, 2050
Figure 10 Company Market Share, 2012
Figure 11 Global Alzheimer prevalence, 2010-2050 (million)
Figure 12 Company Market Share, 2012
Figure 13 Global angioplasty procedures conducted, 2009-2012
Figure 14 Global stents in coronary procedures, 2009-2012
Figure 15 PACS Implementation Process
Figure 16 Global percentage of population, by age-group
Figure 17 Market share of key players, 2012
Figure 18 Cardiovascular mortality percentage, by country income level, 2011
